New Products

N-Ethylheptedrone 4-HO-EPT 3F-PiHP 3-desoxy-MDPV 4-CMA

AD-18 is a new designer cannabinoid developed as a modern replacement for ADB-Butinaca and has similar properties. This drug is an agonist of the CB1 and CB2 receptors. AD-18 product has not been tested enough yet and only recently appeared on the market of designer drugs, has a legal status in many EU countries.

Synonyms AD-18
Molecular weight
Appearance   Powder
Purity    ≥ 98%

AD-18 designer drug sold on this website is designed for research and forensic applications. A chemical research substance called AD-18 .

The side-effects of AD-18 are unknown.

Storage conditions of this chemical: in a cool and dry place. The stability of this chemical compound can last up to 2 years, under the right storage conditions.

EUR 9.00/g

10g 90 EUR

EUR 6.50/g

20g 130 EUR

EUR 3.60/g

50g 180 EUR

EUR 3.00/g

100g 300 EUR

EUR 1.10/g

1k 1100 EUR

Make an order

Contact the manager. (specify the chemical, quantity, address of the recipient)

All orders are sent by EMS, DHL, UPS, TNT, FEDEX delivery services. Shipments come from China, Netherlands(warehouse), Switzerland(warehouse). The availability of goods, delivery time, the price of delivery check with the manager.


– it is the big trading history and experience in the market of research chemicals.
– We accept various payment methods: Bitcoin, MoneyGram, and Payeer.

What do you get when you buy a chemical on
– a printed bag of aluminum foil containing a chemical of the first class AD-18.
-Powder over 98% pure.

We would like to draw your attention to the fact that before placing an order you checked the legality of the necessary chemicals. Independently check the list of prohibited substances in your country. We want you to place an order only for legally permitted substances in your country.

By purchasing chemical research on, you buy a quality chemical at a wholesale price without excess impurities and get a discount coupon for subsequent purchases on our site.

Leave a Reply

Your email address will not be published. Required fields are marked *

Share Article:

error: Content is protected !!